
Currently out of the existing stock ratings of Lee Lueder, 4 are a HOLD (36.36%), 7 are a BUY (63.64%).
Analyst Lee Lueder, has had 91.67% of price targets met with an average potential upside of 19.33%, reached in 150 days on average. Previously, Lee Lueder worked at DEUTSCHE BANK.
Lee Lueder has documented 23 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 22-Mar-2024.
Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) on 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%), with a performance score of 7.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Jul-2025
$400
$85.68 (27.26%)
$330
17 days ago
(05-Nov-2026)
12/13 (92.31%)
$86.98 (27.79%)
150
Buy Since 06-Nov-2025
$375
$60.68 (19.31%)
$330
17 days ago
(05-Nov-2026)
14/15 (93.33%)
$61.98 (19.80%)
51
Buy Since 06-Aug-2026
$352
$37.68 (11.99%)
$322
17 days ago
(05-Nov-2026)
3/3 (100%)
$38.98 (12.45%)
12
Buy Since 28-Sep-2026
$340
$25.68 (8.17%)
$195
1 months 25 days ago
(28-Sep-2026)
34/35 (97.14%)
$45.41 (15.41%)
227
Hold Since 07-Jun-2024
$295
$-19.32 (-6.15%)
$230
1 months 28 days ago
(25-Sep-2026)
12/12 (100%)
$2.16 (0.74%)
33
Stocks Lee Lueder covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.